145 related articles for article (PubMed ID: 3086650)
1. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine.
Petraglia F; Porro C; Facchinetti F; Cicoli C; Bertellini E; Volpe A; Barbieri GC; Genazzani AR
Life Sci; 1986 Jun; 38(23):2103-10. PubMed ID: 3086650
[TBL] [Abstract][Full Text] [Related]
2. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
Rossmanith WG; Mortola JF; Yen SS
J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
[TBL] [Abstract][Full Text] [Related]
4. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
5. Naloxone stimulation of luteinizing hormone secretion in the female monkey: influence of endocrine and experimental conditions.
Van Vugt DA; Bakst G; Dyrenfurth I; Ferin M
Endocrinology; 1983 Nov; 113(5):1858-64. PubMed ID: 6414806
[TBL] [Abstract][Full Text] [Related]
6. Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.
Bondanelli M; Ambrosio MR; Franceschetti P; Guerrini R; Valentini A; degli Uberti EC
Hum Reprod; 1998 May; 13(5):1159-62. PubMed ID: 9647539
[TBL] [Abstract][Full Text] [Related]
7. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
Snowden EU; Khan-Dawood FS; Dawood MY
J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
[TBL] [Abstract][Full Text] [Related]
8. Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female rhesus monkeys.
Mello NK; Mendelson JH; Bree MP; Skupny A
J Pharmacol Exp Ther; 1988 Jun; 245(3):895-904. PubMed ID: 3133465
[TBL] [Abstract][Full Text] [Related]
9. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
Cetel NS; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
[TBL] [Abstract][Full Text] [Related]
10. Effects of morphine and naloxone on plasma levels of LH, FSH, prolactin and growth hormone in the immature male pig.
Trudeau VL; Meijer JC; van de Wiel DF; Bevers MM; Erkens JH
J Endocrinol; 1988 Dec; 119(3):501-8. PubMed ID: 3146613
[TBL] [Abstract][Full Text] [Related]
11. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
[TBL] [Abstract][Full Text] [Related]
12. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
13. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
Cagnacci A; Melis GB; Soldani R; Bonuccelli U; Piccini P; Napolitano A; Muratorio A; Fioretti P
Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
[TBL] [Abstract][Full Text] [Related]
14. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
15. The source of pulsatile secretion of progesterone during the human follicular phase.
Judd S; Terry A; Petrucco M; White G
J Clin Endocrinol Metab; 1992 Feb; 74(2):299-305. PubMed ID: 1730808
[TBL] [Abstract][Full Text] [Related]
16. Effects of naloxone and morphine on the proestrous surge of prolactin and gonadotropins in the rat.
Ieiri T; Chen HT; Campbell GA; Meites J
Endocrinology; 1980 May; 106(5):1568-70. PubMed ID: 6767598
[TBL] [Abstract][Full Text] [Related]
17. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
18. FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile, and postmenopausal women.
Genazzani AD; Petraglia F; Volpogni C; D'Ambrogio G; Facchinetti F; Genazzani AR
Am J Physiol; 1993 May; 264(5 Pt 1):E776-81. PubMed ID: 8498499
[TBL] [Abstract][Full Text] [Related]
19. Alcohol effects on naloxone-stimulated luteinizing hormone, prolactin and estradiol in women.
Mendelson JH; Mello NK; Cristofaro P; Ellingboe J; Skupny A; Palmieri SL; Benedikt R; Schiff I
J Stud Alcohol; 1987 Jul; 48(4):287-94. PubMed ID: 3613578
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lactating sows with the dopamine agonist Cabergoline: effects on LH and prolactin secretion and responses to challenges with naloxone and morphine.
De Rensis F; Quintavalla F; Foxcroft GR
Anim Reprod Sci; 1998 May; 51(3):233-47. PubMed ID: 9675405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
